Evrofarma SA (EVROF) — Capital Reinvestment Ratio
Latest as of December 2022:
0.41x
Evrofarma SA (EVROF) has a Capital Reinvestment Ratio of 0.41x as of December 2022, meaning it reinvests 0% of its operating cash flow (€1.52 Million) in capital expenditures (€615.00K). See Evrofarma SA free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.41x
Capex / Operating Cash Flow
Operating Cash Flow
€1.52 Million
EUR
Capital Expenditures
€615.00K
EUR
Data as of
Dec 2022
Most recent filing
Evrofarma SA Capital Reinvestment Ratio (2014–2022)
This chart tracks Evrofarma SA's Capital Reinvestment Ratio across 8 annual periods.
Annual Capital Reinvestment Ratio for Evrofarma SA (2014–2022)
Year-by-year Capital Reinvestment Ratio for Evrofarma SA from 2014 to 2022. For live market cap and broader valuation context, see EVROF stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.84x | €2.44 Million | €2.05 Million | ▲ +35.8% |
| 2020 | 0.62x | €1.46 Million | €904.00K | ▲ +26.0% |
| 2019 | 0.49x | €1.78 Million | €875.00K | ▲ +37.2% |
| 2018 | 0.36x | €2.29 Million | €822.00K | ▲ +37.5% |
| 2017 | 0.26x | €3.11 Million | €810.00K | ▲ +9.3% |
| 2016 | 0.24x | €1.08 Million | €258.00K | ▼ -35.2% |
| 2015 | 0.37x | €1.39 Million | €512.00K | ▼ -47.4% |
| 2014 | 0.70x | €866.00K | €607.00K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow